Aberrant fatty acid profile and FFAR4 signaling confer endocrine resistance in breast cancer.
Chu X, Zhou Q, Xu Y, Jiang J, Li Q, Zhou Q, Wu Q, Jin M, Wang H, Gu Y, Wang X, Wang B, He S, He X, Wu C, Zhang F, Zhang Y.
Chu X, et al. Among authors: he s, he x.
J Exp Clin Cancer Res. 2019 Feb 22;38(1):100. doi: 10.1186/s13046-019-1040-3.
J Exp Clin Cancer Res. 2019.
PMID: 30795784
Free PMC article.